Immuneering
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuneering and other ETFs, options, and stocks.About IMRX
Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis.
IMRX Key Statistics
Stock Snapshot
As of today, Immuneering(IMRX) shares are valued at $3.98. The company's market cap stands at 260.08M, with a P/E ratio of -3.37.
As of 2026-06-09, Immuneering(IMRX) stock has fluctuated between $3.90 and $4.14. The current price stands at $3.98, placing the stock +2.1% above today's low and -3.9% off the high.
The Immuneering(IMRX)'s current trading volume is 1.38M, compared to an average daily volume of 2.78M.
In the last year, Immuneering(IMRX) shares hit a 52-week high of $10.08 and a 52-week low of $1.66.
In the last year, Immuneering(IMRX) shares hit a 52-week high of $10.08 and a 52-week low of $1.66.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.